Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Oral Cancer Diagnostics Market Share

ID: MRFR//6614-CR | 121 Pages | Author: Rahul Gotadki| July 2019

Oral Cancer Diagnostics Market Share Analysis

In the year 2018, the Americas emerged as the front-runner in the market, securing the largest share at 42.38%, valued at USD 1,852.35 million. The market is set for growth, with an expected rise at a rate of 7.13% during the forecast period. Following closely, Europe took the position of the second-largest market in 2018, with a value of USD 1,230.08 million, and is anticipated to grow at a rate of 6.40%. The Asia-Pacific market is poised for the highest growth rate, projected to experience an expected Compound Annual Growth Rate (CAGR) of 8.03%. Now, let's explore the specifics of Mucoepidermoid Carcinoma (MEC), a distinct type of tumor commonly found in the minor salivary gland in adults. This tumor may also occur in the thyroid gland, bronchi, and lacrimal sac. While it is less common in the submandibular glands or minor salivary glands inside the mouth, certain factors like old age, exposure to radiation, and workplace contact with substances such as asbestos mining, plumbing, and rubber manufacturing increase the risk of salivary gland tumors. According to the Oral Cancer Foundation, MEC accounts for approximately 35% of all malignancies affecting major and minor salivary glands globally. The growing prevalence of salivary gland cancers worldwide is expected to drive the demand for diagnostics, contributing to market growth during the forecast period. Information from the American Cancer Society in September 2017 indicates that salivary gland cancer constitutes less than 1% of cancers in the US, occurring at a rate of about 1 case per 100,000 individuals per year. The diagnosis of MEC involves various methods such as X-ray, computed tomography, magnetic resonance imaging, positron emission tomography, and biopsy. These diagnostic tools play a crucial role in identifying and understanding the characteristics of Mucoepidermoid Carcinoma, enabling healthcare professionals to make informed decisions about treatment strategies. The ongoing advancements in diagnostic technologies further contribute to enhancing the accuracy and efficiency of MEC diagnosis. In conclusion, the regional market dynamics and the specific case of Mucoepidermoid Carcinoma highlight the complexities and nuances in the field of oral cancer diagnostics. As the market continues to evolve, propelled by technological innovations and increasing awareness, it is poised for sustained growth, particularly in the context of addressing specific types of oral cancers like Mucoepidermoid Carcinoma. Covered Aspects:

Report Attribute/Metric	Details
Base Year For Estimation	2021 Forecast Period 2023-2032 Historical Data 2020 Forecast Units Value (USD Million) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Indication, Diagnosis Type, End User Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors Thermo Fisher Scientific Inc. (U.S.), Hoffmann-La Roche Ltd (Switzerland), Vigilant Biosciences Inc. (U.S.), Koninklijke Philips NV (Netherlands), Hitachi Ltd (Japan), Philips NV (Netherlands), QIAGEN (Germany), E. Healthcare (U.S.), Recent Developments, Koninklijke Philips NV (Netherlands), PeriRx LLC (U.S.) Key Market Opportunities New product launches and R&D Amongst major key Players Key Market Drivers· Increasing number of cases in the sector of oral cancer· Growing pervasiveness for oral cancer· Increased technological advancements for better facilities· Diagnostic tools
Historical Data	2020 Forecast Units Value (USD Million) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Indication, Diagnosis Type, End User Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors Thermo Fisher Scientific Inc. (U.S.), Hoffmann-La Roche Ltd (Switzerland), Vigilant Biosciences Inc. (U.S.), Koninklijke Philips NV (Netherlands), Hitachi Ltd (Japan), Philips NV (Netherlands), QIAGEN (Germany), E. Healthcare (U.S.), Recent Developments, Koninklijke Philips NV (Netherlands), PeriRx LLC (U.S.) Key Market Opportunities New product launches and R&D Amongst major key Players Key Market Drivers· Increasing number of cases in the sector of oral cancer· Growing pervasiveness for oral cancer· Increased technological advancements for better facilities· Diagnostic tools
Forecast Period	2023-2032 Historical Data 2020 Forecast Units Value (USD Million) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Indication, Diagnosis Type, End User Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors Thermo Fisher Scientific Inc. (U.S.), Hoffmann-La Roche Ltd (Switzerland), Vigilant Biosciences Inc. (U.S.), Koninklijke Philips NV (Netherlands), Hitachi Ltd (Japan), Philips NV (Netherlands), QIAGEN (Germany), E. Healthcare (U.S.), Recent Developments, Koninklijke Philips NV (Netherlands), PeriRx LLC (U.S.) Key Market Opportunities New product launches and R&D Amongst major key Players Key Market Drivers· Increasing number of cases in the sector of oral cancer· Growing pervasiveness for oral cancer· Increased technological advancements for better facilities· Diagnostic tools
Growth Rate	4.8% Base Year 2021 Forecast Period 2023-2032 Historical Data 2020 Forecast Units Value (USD Million Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Indication, Diagnosis Type, End User Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW) Key Vendors Thermo Fisher Scientific Inc. (U.S.), Hoffmann-La Roche Ltd (Switzerland), Vigilant Biosciences Inc. (U.S.), Koninklijke Philips NV (Netherlands), Hitachi Ltd (Japan), Philips NV (Netherlands), QIAGEN (Germany), E. Healthcare (U.S.), Recent Developments, Koninklijke Philips NV (Netherlands), PeriRx LLC (U.S.) Key Market Opportunities New product launches and R&D Amongst major key Players Key Market Drivers· Increasing number of cases in the sector of oral cancer· Growing pervasiveness for oral cancer· Increased technological advancements for better facilities· Diagnostic tools

Oral Cancer Diagnostics Market Highlights:

Oral Cancer Diagnostics Market Trends

Oral Cancer Diagnostics Market Analysis

Oral Cancer Diagnostics Market Size

Oral Cancer Diagnostics Companies

Oral Cancer Diagnostics Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions